Skip to main content

Microbot Medical Inc.

MBOT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000883975

No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Microbot Medical Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of MBOT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders2529+4
Shares795.1K754.9K−40.1K (−5.0%)
Value$6.77M$6.00M−$770.7K (−11.4%)

New holders (7)

Institutions that held Microbot Medical Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to MBOT in Q2 2021
InstitutionSharesValue% of portfolio
Dimensional Fund Advisors LP53,378$424.0K0.00%
Renaissance Technologies LLC40,113$318.0K0.00%
State Street Corp34,470$274.0K0.00%
The PNC Financial Services Group, Inc.1,000$8.00K0.00%
JPMorgan Chase & Co418$3.00K0.00%
Pacific Center for Financial Services1$00.00%
Alaethes Wealth LLC1$00.00%

Sold out (3)

Institutions that held Microbot Medical Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of MBOT in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
XXEC, Inc.92,628$788.0K
Millennium Management LLC11,231$96.0K
Sound Income Strategies, LLC1$9